NAME: Michael Hayden, CM, OBC, MB, ChB, PhD, FRCP(C), FRSC CURRENT
Dr. Michael Hayden was recently appointed as the President of Global Research and Development and Chief Scientific Officer at Teva Pharmaceuticals. Dr. Hayden is the most highly cited author in Huntington disease. He is the founder and director of the Centre for Molecular Medicine and Therapeutics in Vancouver, and founder of three biotechnology companies (NeuroVir, Xenon Genetics, and Aspreva Pharmaceuticals).
POSITION: President of Global Research and Development and Chief Scientific Officer at Teva Pharmaceuticals
OTHER POSITIONS: Killam Professor of Medical Genetics at the University of British Columbia, Canada Research Chair in Human Genetics and Molecular Medicine, Founder and director for the Center for Molecular Medicine and Therapeutics in Vancouver, Canada, Program director of the Translational Laboratory in Genetic Medicine at the National University of Singapore, Founder of NeuroVir, Xenon Genetics, Inc., and Aspreva Pharmaceuticals, Inc
EDUCATION: MB, ChB, PhD, University of Cape Town, Post-doctoral fellowship, Harvard University
HOBBIES: Collecting art, photography, and enjoying creativity in other domains.
FAVORITE ARTIST: Ben Shahn, who was born in Lithuania and became a social activist in America. He is known for his works of social realism.